Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S B New
(OP:
NONOF
)
49.75
-0.21 (-0.43%)
Streaming Delayed Price
Updated: 3:59 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,898
Open
48.45
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
49.96
Today's Range
47.60 - 50.87
52wk Range
40.25 - 93.83
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition
↗
June 24, 2024
The greater weight loss in women did not result in significantly better improvements in heart failure symptoms.
Via
Benzinga
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
↗
June 21, 2024
As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide.
Via
Benzinga
Performance
YTD
-5.7%
-5.7%
1 Month
-11.4%
-11.4%
3 Month
+5.3%
+5.3%
6 Month
-8.7%
-8.7%
1 Year
-36.4%
-36.4%
More News
Read More
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
↗
June 07, 2024
Via
InvestorPlace
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments
↗
May 14, 2024
Via
Benzinga
7 Mutual Funds That Will Outperform in Any Market
↗
February 03, 2024
Via
InvestorPlace
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label
↗
September 11, 2023
Via
Benzinga
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector
↗
November 23, 2023
Via
Benzinga
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
↗
October 09, 2023
Via
Benzinga
Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian
↗
July 03, 2023
Via
Benzinga
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert
↗
August 17, 2022
Via
Benzinga
Frequently Asked Questions
Is Novo Nordisk A/S B New publicly traded?
Yes, Novo Nordisk A/S B New is publicly traded.
What exchange does Novo Nordisk A/S B New trade on?
Novo Nordisk A/S B New trades on the OTC Traded
What is the ticker symbol for Novo Nordisk A/S B New?
The ticker symbol for Novo Nordisk A/S B New is NONOF on the OTC Traded
What is the current price of Novo Nordisk A/S B New?
The current price of Novo Nordisk A/S B New is 49.75
When was Novo Nordisk A/S B New last traded?
The last trade of Novo Nordisk A/S B New was at 02/13/26 03:59 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today